PCSK9-inhibitors Take Center Stage at ACC

Six Phase III clinical trials involving PCSK9-inhibitors will be presented at the ACC Scientific Sessions in Washington, DC. Two have been accepted for the Late-Breaking Clinical Trials Sessions, GAUSS-2 and LAPLACE-2. 

SELF STUDY

Exploring the Future of Acute Heart Failure Management: A Review of the Evidence
 
A Case Based Approach to Improving the Management of Acute Coronary Syndrome in the Emergency Room
 
Contemporary, Challenging and Controversial Issues in Atrial Fibrillation Management

CONFERENCES

VBWG U. S. Chapter Meeting
Washington, DC
March 28, 2014
 
Translating Evidence and Excellence in Stroke Care
Gainesville, FL
May 30-31, 2014
 
Heart Failure Management: Personalized Medicine to Optimize Care
Amelia Island, FL
July 17-20, 2014

Vascular Biology in Clinical Practice TM Vol. 7, No. 2

New Frontiers in CVD Risk Management Supporting Early Aggressive Therapy

This monograph, New Frontiers in CVD Risk Management Supporting Early Aggressive Therapy , is offered as part of a series of continuing medical education activities from the University of Florida College of Medicine.

Vascular Biology in Clinical Practice © Vol. 7, No. 1

ACE Inhibition in CAD Patients: Expanding the Reach of Cardioprotection

This monograph, ACE Inhibition in CAD Patients: Expanding the Reach of Cardioprotection , which is being offered as part of a series of continuing medical education activities from the University of Florida College of Medicine.

Vascular Biology in Clinical Practice © Vol. 6, No. 3

A HOPE FOR PEACE? Update on the role of ACE inhibition in CAD patients

This monograph, A HOPE for PEACE? Update on the role of ACE inhibition in CAD patients , is offered as part of a series of continuing medical education activities from the University of Florida College of Medicine.